Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the Founders of “The...

MINNEAPOLIS, MN, Sept. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Mitesco, Inc. (OTCQB: MITI) today announced that The Good Clinic, LLC has filed...
biotech stock review

7 Million Telehealth Users This Year, Expected to Drive Revenues to $36 Billion in...

As boomers age, experts predict the telehealth market will grow from a $14.3 billion industry in 2013 to a $36.2 billion...
GBT Technologies

GBT (GTCH) Is Researching To Develop An AI Empowered, Wireless Patient Health Monitoring System

The researched technology, is aiming to create a Radio-Based patient health monitoring system for homes or facilities SAN...
ehave, psychedelic stock review

Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine...
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.

Latest article

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...